Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →

Community Q&A

What does SS-31 do?
Community accounts describe SS-31 (elamipretide) as a mitochondria-targeting peptide that concentrates at the inner mitochondrial membrane — reducing oxidative damage and preserving mitochondrial function. Most accounts come from longevity-focused users treating it as foundational cellular protection rather than a performance compound. The most commonly described subjective effects: improved energy, reduced fatigue, and better recovery. SS-31 accounts frequently appear alongside humanin and MOTS-c in mitochondrial optimisation stacks — framed as infrastructure rather than enhancement.
How is SS-31 administered?
Subcutaneous injection appears in all community accounts for SS-31 — there is no established oral or nasal route in confessions. Daily dosing is the most common protocol. SS-31 is among the more expensive compounds in typical community accounts, and price is consistently cited as the limiting factor in access. Most accounts describe cycles of 30–60 days rather than indefinite continuous use, driven by cost as much as protocol design.